Industry1h ago
Illumina Adds AI Drug Developers To Cell Atlas
Three AI-driven drug developers joined the Billion Cell Atlas alliance to leverage large-scale genomic data. Illumina aims to accelerate the approval of precision medicines through this expanded partnership. The move provides researchers with higher-resolution cellular maps. This incremental expansion focuses on scaling data availability for specialized pharmaceutical discovery pipelines.